R-cmop and pola-R-CMP regimens as first-line treatment for diffuse large B-cell lymphoma with cardiac comorbidity: A prospective, single-arm, multicenter study
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-1920
Abstract: Introduction: Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin lymphoma (NHL), accounts for approximately 30% of newly diagnosed NHL, with approximately 150,000 new cases annually worldwide. The median age at diagnosis is… read more here.
Keywords: treatment; pola; first line; cmop pola ... See more keywords